Stockreport

Scinai Regains Full Compliance with Nasdaq Listing Requirements

Scinai Immunotherapeutics Ltd. - American Depositary Shares  (SCNI) 
PDF JERUSALEM, Aug. 29, 2024 /PRNewswire/ -- Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) ("Scinai", or the "Company"), a biopharmaceutical company focused on developing in [Read more]